About the Authors:
Mst. Mahmuda Ackhter
Roles Conceptualization, Data curation, Formal analysis, Methodology, Software, Validation, Visualization, Writing – original draft
Affiliation: Nutrition and Clinical Services Division, International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b), Dhaka, Bangladesh
Abu Sadat Mohammad Sayeem Bin Shahid
Roles Conceptualization, Data curation, Formal analysis, Funding acquisition, Methodology, Software, Supervision, Validation, Visualization, Writing – review & editing
* E-mail: [email protected]
Affiliation: Nutrition and Clinical Services Division, International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b), Dhaka, Bangladesh
ORCID logo https://orcid.org/0000-0002-7759-974X
Tahmeed Ahmed
Roles Conceptualization, Formal analysis, Validation, Writing – review & editing
Affiliation: Nutrition and Clinical Services Division, International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b), Dhaka, Bangladesh
Parag Palit
Roles Data curation, Formal analysis, Validation, Visualization, Writing – review & editing
Affiliation: Nutrition and Clinical Services Division, International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b), Dhaka, Bangladesh
Irin Parvin
Roles Data curation, Methodology, Writing – review & editing
Affiliation: Nutrition and Clinical Services Division, International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b), Dhaka, Bangladesh
Md. Zahidul Islam
Roles Formal analysis, Validation, Writing – review & editing
Affiliation: Nutrition and Clinical Services Division, International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b), Dhaka, Bangladesh
Tahmina Alam
Roles Data curation, Methodology, Writing – review & editing
Affiliation: Nutrition and Clinical Services Division, International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b), Dhaka, Bangladesh
Shamsun Nahar Shaima
Roles Methodology, Validation, Visualization, Writing – review & editing
Affiliation: Nutrition and Clinical Services Division, International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b), Dhaka, Bangladesh
Lubaba Shahrin
Roles Data curation, Formal analysis, Validation, Visualization, Writing – review & editing
Affiliation: Nutrition and Clinical Services Division, International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b), Dhaka, Bangladesh
ORCID logo https://orcid.org/0000-0002-5676-3280
Farzana Afroze
Roles Methodology, Visualization, Writing – review & editing
Affiliation: Nutrition and Clinical Services Division, International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b), Dhaka, Bangladesh
Monira Sarmin
Roles Methodology, Visualization, Writing – review & editing
Affiliation: Nutrition and Clinical Services Division, International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b), Dhaka, Bangladesh
Shoeb Bin Islam
Roles Methodology, Visualization, Writing – review & editing
Affiliation: Nutrition and Clinical Services Division, International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b), Dhaka, Bangladesh
Zubair Akhtar
Roles Methodology, Visualization, Writing – review & editing
Affiliation: Infectious Diseases Division, International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b), Dhaka, Bangladesh
Mohammod Jobayer Chisti
Roles Conceptualization, Formal analysis, Methodology, Validation, Visualization, Writing – review & editing
Affiliation: Nutrition and Clinical Services Division, International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b), Dhaka, Bangladesh
Fahmida Chowdhury
Roles Conceptualization, Data curation, Formal analysis, Funding acquisition, Methodology, Project administration, Resources, Supervision, Validation, Visualization, Writing – review & editing
Affiliation: Infectious Diseases Division, International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b), Dhaka, Bangladesh
Introduction
The Bacillus Calmette-Guérin (BCG) vaccine, initially developed attenuating a strain of Mycobacterium bovis [1] is one of the oldest and most commonly administered vaccines worldwide. Albert Calmette and Camille Guérin, two pioneer scientists invented the vaccine in early 1900s by attenuating a strain of Mycobacterium bovis that was closely related to Mycobacterium tuberculosis, causing bovine tuberculosis (TB) [1]. The World Health Organization (WHO) implemented Expanded Programme on Immunization (EPI) in Bangladesh on 1979 having its lower impact until 1985. Later on, government took an initiative to improve childhood vaccination coverage from 1985 onwards. The United Nations Children’s Fund and the WHO estimated that individual vaccine coverage in Bangladesh in 2015 for BCG was 98% [2]. Although BCG vaccine is intended to prevent tuberculosis, it may also have some non-specific benefits, potentially in reducing morbidity and mortality [3]. Historical data as well as data from an observational study conducted in low and middle income countries by Roth et al, [4–8] have suggested that BCG vaccine may have some nonspecific beneficial effects on child survival [9].
BCG induces functional changes in the innate and adaptive immune compartments in the first year of life. Understanding the biological mechanisms beyond its heterogeneous effects is crucial to improve the protection that the vaccine confers to the infants from infectious diseases [10]. Some human and animal studies suggested that priming with one pathogen may trigger innate immune responses or induce heterologous T-cell mediated immunity, thus reducing the susceptibility to subsequent infections with Mycobacterium tuberculosis and thus also proving that BCG vaccine has its non-specific effects [11–14]. In the neonatal period, BCG vaccine has been reported to induce strong Th1 responses [15] and also stimulate Th1 and Th17 responses to non-mycobacterial pathogens [16–18]. Findings from two separate studies also concluded that BCG vaccination protects against non-mycobacterial infections, especially against sepsis and other respiratory infections [19,20]. WHO’s Strategic Advisory Group of Experts on Immunization also concluded that BCG and measles vaccine may have beneficial effects and advocated for further research to address this specific issue [21].
Malnutrition accounts for 35% of all cases of morbidities among children less than five years of age and for around 3.5 million cases of annual global mortality, thereby distinctly indicating that malnutrition, a salient cause of life threatening conditions among such children in developing countries [22]. In Bangladesh, prevalence of under-five stunting, wasting and underweight are 36%, 14% and 33%, respectively [23]. A prospective study conducted by Chisti et al, from April 2011 to June 2012 concluded that severely malnourished children are also commonly affected with TB, especially in TB endemic areas, like Bangladesh [24].
Following introduction of BCG vaccine in the 1920’s, experts in the field of infectious diseases had been in concurrence that BCG vaccine had intermittent heterogeneous protective effects on childhood morbidity and mortality beyond the spectrum of the particular protection against tuberculosis [25]. Considering the non-specific effects of BCG vaccination and the burden of TB among severely malnourished under-five children in Bangladesh, this study aimed to evaluate the characteristics and outcomes of BCG vaccinated children.
Materials and methods
Ethical consideration
This study (PR-15011) was approved by the institutional review board (comprised of research review committee and ethical review committee) of International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b). Written, informed consent was obtained from the caregivers before enrolling the children in this study.
Study setting and design
The study was carried out in the Dhaka Hospital of icddr,b. Each year, the hospital offers free of cost treatment to around 150,000 patients, among whom 60% are children under the age of five years admitted with history of diarrhea and or acute respiratory infections and other associated complications. The vast majority of the patients live in urban and peri-urban Dhaka city and belong to poor socio-economic background.
A total of 1163 under-five children suffering from severe malnutrition was screened under a prospective observational study conducted to evaluate the viral etiology of pneumonia. Among them, 694 children met the inclusion criteria (severely malnourished under-five children of either sex admitted with acute illnesses, like diarrhea, pneumonia). We excluded 469 children due to non-consent and chance of migration leading to lost to follow up in that prospective study (Fig 1). By analyzing the data using a case control design, where children having BCG vaccination prior hospital admission were considered as cases (n = 611) and those without BCG vaccination were considered as controls (n = 83). Comparison of socio-demographic, clinical, laboratory, and treatment characteristics on admission and their outcomes during hospitalization was carried out between the groups.
[Figure omitted. See PDF.]
Fig 1. Study profile.
https://doi.org/10.1371/journal.pone.0262391.g001
Case definition
Severe malnutrition: WHO criteria <-3 z score from the median of weight for height/length, weight for age, or nutritional edema [26].
Paternal and maternal illiteracy: Parents who did not attend formal schooling [26].
Dehydration (some/severe): Defined by the Dhaka method, which is almost similar to the WHO method and approved by that organization [27].
Pneumonia: If a child presents with severe malnutrition with any sign of pneumonia (any of the WHO defined signs of pneumonia or severe pneumonia or radiological pneumonia) would be considered as pneumonia [28].
Severe wasting: z-score for weight for length/height <-3 of the WHO growth standard [29].
Severe underweight: z-score for weight for age <-3 of the WHO growth standard [29].
Severe sepsis: Defined as sepsis with sepsis-induced organ dysfunction or tissue hypo-perfusion [30].
Heart failure: Defined as a clinical and pathophysiologic syndrome that results from ventricular dysfunction, volume, or pressure overload, alone or in combination [31].
Respiratory failure: Defined as the presence of any one of the following phrases: mechanical ventilation, intubation, oxygen, continuous positive airway pressure (CPAP), bubble CPAP, nasal cannula, or ventilator [32].
Hypoglycemia: random blood sugar <3.0 mmol/L [33].
Abnormal C-reactive protein: ≥ 1 mg/dl [33].
Hyponatremia: serum sodium <130.0 mmol/L [33].
Hypernatremia: serum sodium >150.0 mmol/L [34].
Hypokalemia: serum potassium <3.5 mmol/L [33].
Patient management
Antibiotics and other supportive care were provided in line with the hospital’s treatment protocol for severe malnutrition (S1 Appendix). Trained study physicians followed up the patients and recorded their clinical parameters daily in the electronic database. Treatment changes were performed based upon either clinical deterioration or non-improvement of clinical findings after 48 hours following hospitalization. If patients required treatment for health-related complications that was not available at the hospital, like renal dialysis or any kind of surgical interventions, they were immediately referred to other specialized hospitals designated for such treatments.
Measurements
Trained study physicians and research assistants collected data from caregivers during admission and filled in specially designed and well-structured case report forms.
Data on socio-demographic and vaccination status was collected. Clinical characteristics included the presence of fever, diarrhea, dehydration (some/severe), pedal edema, pneumonia, severe wasting, and severe underweight. The laboratory tests variables assessment for hypoglycemia, abnormal C-reactive protein levels, hypokalemia, hyponatremia, hypernatremia, positive bacterial culture and viral polymerase chain reaction (PCR) during hospitalization was performed (Table 1). Treatment characteristics of both the groups were also collected and recorded during hospitalization (Table 2). Outcome characteristics were severe sepsis, heart failure, respiratory failure, and death during hospitalization and also duration of hospital stay (Table 3). Finally, log-linear binomial regression analysis was done to see the independent impact of BCG vaccination.
[Figure omitted. See PDF.]
Table 1. Comparison of socio-demographic, clinical and laboratory characteristics of severely malnourished under-five children with (cases) and without (control) BCG vaccination on admission.
https://doi.org/10.1371/journal.pone.0262391.t001
[Figure omitted. See PDF.]
Table 2. Comparison of treatment characteristics of severely malnourished under-five children with (cases) and without (control) BCG vaccination during hospitalization.
https://doi.org/10.1371/journal.pone.0262391.t002
[Figure omitted. See PDF.]
Table 3. Outcomes of severely malnourished under-five children with (cases) and without (control) BCG vaccination during hospitalization.
https://doi.org/10.1371/journal.pone.0262391.t003
Statistical analysis
Data was entered using SPSS for Windows version 20.0 (SPSS Inc, Chicago, IL), and analyzed using STATA version 13 (College Station, Texas). For qualitative variables, differences in proportions were compared by the Chi-square or Fisher’s exact test, where appropriate. Differences in means for normally distributed quantitative data were compared by the Student’s t-test and the Mann-Whitney U test was used for comparison of non-parametric data. A probability of less than 0.05 was considered statistically significant. The strength of association was determined by calculating the odds ratio (OR) or relative risk (RR), as appropriate and their 95% confidence intervals (CIs). In the bi-variate model, socio-demographic, clinical and laboratory characteristics that were analyzed during admission included age, male sex, paternal and maternal illiteracy, caregiver’s monthly income, residence, breastfeeding history, fever, diarrhea, dehydration status (some/severe), pedal edema, pneumonia, severe wasting, severe underweight, hypoglycemia, abnormal C-reactive protein levels, hypokalemia, hyponatremia, hypernatremia, positive bacterial culture and viral PCR. In another bi-variate analysis, outcome characteristics analyzed included severe sepsis, heart failure, respiratory failure, and death as well as duration of hospital stay. Finally, log-linear binomial regression analysis was performed to identify whether BCG vaccination had independent association with worse outcomes, such as severe sepsis, after adjusting with potential confounders.
Results
1163 children, aged 0–59 months admitted to the Dhaka Hospital’s intensive care unit or longer stay unit with severe malnutrition during the study period. We analysed data of 694 children out of 1163, after obtaining informed written consent from parents/caregivers (Fig 1). Among them, 611 were cases and 83 were controls. During admission, the cases presented with older age, have had lower proportion of maternal illiteracy, higher rate of breastfeeding, severe wasting and lower rate of hypoglycemia, compared to the controls (Table 1). Other characteristics, like positive bacterial culture and viral PCR were comparable between the groups (Table 1). Treatment characteristics among the groups were also comparable (Table 2). In another bi-variate analysis, the cases were found to be significantly associated with lower risk of severe sepsis and deaths, compared to the controls (Table 3). In log-linear binomial regression analysis, after adjusting for potential confounders, age, BCG vaccination following EPI schedule and breastfeeding remained to be protective for the development of severe sepsis (Table 4). When we kept death as dependent variable in another regression model, we didn’t find any significant association of BCG vaccination with death (RR: 0.86; 95%CI = 0.43–1.72; p = 0.679).
[Figure omitted. See PDF.]
Table 4. Results of log-linear binomial regression analysis to explore the independently associated factors with severe sepsis in severely malnourished under-five children.
https://doi.org/10.1371/journal.pone.0262391.t004
Discussion
The main observation of this study was the protective effect of BCG vaccination following EPI schedule and breastfeeding for the development of severe sepsis during hospitalization of severely malnourished under-five children.
The observation of heterogenous protective effect of BCG vaccination for development of severe sepsis is explicable. Cell mediated and humoral immunity is usually depressed in severely malnourished children making them highly vulnerable to infectious diseases. In a recent study, lack of BCG vaccination was found to be one of the predicting factors for severe sepsis among severely malnourished under-five children hospitalized with pneumonia [35], which corroborates with the findings of this study.
The beneficial effects of BCG vaccination on non-tubercular illness have been well documented. BCG vaccination has been reported to reduce around 50% of deaths from non-tubercular infections in developing countries with high childhood mortality. This may reflect growing evidence on substantial heterogeneous effects of BCG vaccination in children, including its potentials for reducing the incidence of severe sepsis in TB endemic developing countries, like Bangladesh. This carries an important message for the clinicians as well as policymakers, especially in developing countries, where severe sepsis related deaths are high, for promoting BCG vaccination [36,37].
We also observed the protective effect of breastfeeding to halt severe sepsis in our study children. Severely malnourished children who were non-breastfed at their neonatal period, were more prone to develop severe sepsis compared to breastfed children which signifies the importance of continuation of breastfeeding in infancy and supports our study findings [35]. In addition to breast milk’s nutritional advantages, it reduces frequency of infections, particularly gastrointestinal [38,39] and respiratory tract [39–42] through specific and non-specific immune factors [43]. A study conducted in Ethiopia showed breastfeeding might reduce mortality by 59% among breastfed under-five SAM children in comparison to those who were non-breastfed [44].
We also observed the protective effect of older age for the development of severe sepsis in our study that might be due to potentially having better immunity of older children than their younger counterpart [45].
In the bi-variate analysis, we also observed lower risk of death in our study children immunized with BCG, although the association became insignificant after adjusting for potential confounders. However, a number of previous studies revealed the protective effect of BCG vaccination in reducing deaths. Findings from a study conducted by Chisti et al, showed lack of BCG vaccination to be an independent predictor of bacteremia leading to mortality among severely malnourished children aged less than 5 years of age [46]. Study conducted by Roy P et al, showed administration of BCG vaccine at birth reduces all-cause mortality for its non-specific beneficial effects, in addition to its beneficial effect on reduction of mortality from tuberculosis [47]. Another study conducted by Hervie S et al, also came up with the same result [48]. Ritz et al, concluded that BCG vaccine had heterogeneous beneficial impact and influence the antibody response when administered at birth which may lead to reduce mortality in late infancy [49]. Study conducted by Nankabirwa V et al, showed children vaccinated with BCG had lower mortality, compared to non-vaccinated children [50].
The major strength of our study was that it aimed to determine the heterogeneous impact of BCG vaccination prior hospital admission in severely malnourished under-five children that was unique in the context of clinical research in this particular field. Another strength of the study was its design, which helped to ensure minimum statistical errors during the analysis. However, a major limitation of this study was involved with an overall comparatively low and mismatched sample size between the cases and the controls, thus providing a possible confounding effect in drawing pertinent statistical inference.
Conclusion
The results of our study helped us to draw an inference that BCG vaccination following EPI schedule and breastfeeding were found to be protective for the development of severe sepsis among children hospitalized for severe malnutrition. The observation underscores the importance of scrupulously adhering to EPI guidelines for continuation of BCG vaccination in order to reduce the risk of non-tubercular illness, such as severe sepsis that may lead to reduced mortality during hospitalization among severely malnourished children, especially in TB endemic countries. It is more likely that timely BCG vaccination is a marker of better clinical care early in life and possibly more of a marker of social determinants of health. Further research with a larger sample is imperative to define the path towards obtaining unequivocal evidence on these issues that would support future robust, evidence-based adjustments in immunization policies, especially in resource constrained settings.
Supporting information
S1 Appendix.
https://doi.org/10.1371/journal.pone.0262391.s001
(DOCX)
Acknowledgments
We would like to express our sincere thanks to all research physicians, nurses, other research and hospital staff for their invaluable support and contribution during patient enrollment and data collection. We would like to express our gratitude to care-givers/ mothers of the study participants for their consent to enroll their children in the study.
Citation: Ackhter MM, Shahid ASMSB, Ahmed T, Palit P, Parvin I, Islam MZ, et al. (2022) Characteristics of severely malnourished under-five children immunized with Bacillus Calmette-Guérin following Expanded Programme on Immunization schedule and their outcomes during hospitalization at an urban diarrheal treatment centre, Bangladesh. PLoS ONE 17(1): e0262391. https://doi.org/10.1371/journal.pone.0262391
1. Fritschi N, Curtis N, Ritz NJPRR. Bacille Calmette Guérin (BCG) and new TB vaccines: specific, cross-mycobacterial and off-target effects. 2020.
2. Boulton ML, Carlson BF, Power LE, Wagner ALJIJoID. Socioeconomic factors associated with full childhood vaccination in Bangladesh, 2014. 2018;69:35–40.
3. Aaby P, Andersen A, Ravn H, Zaman KJE. Co-administration of BCG and diphtheria-tetanus-pertussis (DTP) vaccinations may reduce infant mortality more than the WHO-schedule of BCG first and then DTP. A re-analysis of demographic surveillance data from rural Bangladesh. 2017;22:173–80.
4. Aronson JDJArot. Protective vaccination against tuberculosis with special reference to BCG vaccination. 1948;58(3):255–81. pmid:18891458
5. Ferguson R, Sijmes AJT. BCG Vaccination of Indian Infants in Saskatchewan.(A Study carried out with Financial Assistance from the National Research Council of Canada.). 1949;30(1):5–11. pmid:18102809
6. HART PAJBMJ. BCG and Vole Bacillus Vaccines in the Prevention of Tuberculosis in Adolescents. First (Progress) Report to the Medical Research Council by their Tuberculosis Vaccines Clinical Trials Committee. 1956:413–27.
7. Levine MI, Sackett MJArot. Results of BCG immunization in New York city. 1946;53(6):517–32. pmid:20992285
8. Rosenthal SR, Loewinsohn E, Graham ML, Liveright D, Thorne MG, Johnson V, et al. BCG vaccination in tuberculous households. 1961;84(5P1):690–704. pmid:14494078
9. Aaby P, Roth A, Ravn H, Napirna BM, Rodrigues A, Lisse IM, et al. Randomized trial of BCG vaccination at birth to low-birth-weight children: beneficial nonspecific effects in the neonatal period? 2011;204(2):245–52. pmid:21673035
10. Butkeviciute E, Jones CE, Smith SGJFm. Heterologous effects of infant BCG vaccination: potential mechanisms of immunity. 2018;13(10):1193–208. pmid:30117744
11. Benn CS, Netea MG, Selin LK, Aaby PJTii. A small jab–a big effect: nonspecific immunomodulation by vaccines. 2013;34(9):431–9. pmid:23680130
12. Kleinnijenhuis J, Quintin J, Preijers F, Joosten LA, Ifrim DC, Saeed S, et al. Bacille Calmette-Guerin induces NOD2-dependent nonspecific protection from reinfection via epigenetic reprogramming of monocytes. 2012;109(43):17537–42. pmid:22988082
13. Netea MG, Quintin J, Van Der Meer JWJCh, microbe. Trained immunity: a memory for innate host defense. 2011;9(5):355–61.
14. Welsh RM, Selin LKJNRI. No one is naive: the significance of heterologous T-cell immunity. 2002;2(6):417–26.
15. Messina NL, Gardiner K, Donath S, Flanagan K, Ponsonby A-L, Shann F, et al. Study protocol for the Melbourne Infant Study: BCG for Allergy and Infection Reduction (MIS BAIR), a randomised controlled trial to determine the non-specific effects of neonatal BCG vaccination in a low-mortality setting. 2019;9(12):e032844.
16. Marchant A, Goetghebuer T, Ota MO, Wolfe I, Ceesay SJ, De Groote D, et al. Newborns develop a Th1-type immune response to Mycobacterium bovis bacillus Calmette-Guerin vaccination. 1999;163(4):2249–55. pmid:10438968
17. Kleinnijenhuis J, Quintin J, Preijers F, Benn CS, Joosten LA, Jacobs C, et al. Long-lasting effects of BCG vaccination on both heterologous Th1/Th17 responses and innate trained immunity. 2014;6(2):152–8. pmid:24192057
18. Messina N, Zimmermann P, Curtis NJCM, Infection. The impact of vaccines on heterologous adaptive immunity. 2019;25(12):1484–93.
19. de Castro MJ, Pardo-Seco J, Martinón-Torres FJCID. Nonspecific (heterologous) protection of neonatal BCG vaccination against hospitalization due to respiratory infection and sepsis. 2015;60(11):1611–9. pmid:25725054
20. Hollm-Delgado M-G, Stuart EA, Black . Acute lower respiratory infection among Bacille Calmette-Guérin (BCG)–vaccinated children. 2014;133(1):e73–e81. pmid:24379224
21. Higgins J, Soares-Weiser K, Reingold A, editors. Systematic review of the non-specific effects of BCG. DTP and measles containing vaccines Available from: http://www/who/int/immunization/sage/meetings/2014/april/3_NSE_Epidemiology_review_Report_to_SAGE_14_Mar_FINAL.pdf; 2014.
22. Das S, Gulshan JJBN. Different forms of malnutrition among under five children in Bangladesh: a cross sectional study on prevalence and determinants. 2017;3(1):1.
23. Chowdhury F, Shahid ASMSB, Ghosh PK, Rahman M, Hassan MZ, Akhtar Z, et al. Viral etiology of pneumonia among severely malnourished under-five children in an urban hospital, Bangladesh. 2020;15(2):e0228329.
24. Chisti MJ, Graham SM, Duke T, Ahmed T, Ashraf H, Faruque ASG, et al. A prospective study of the prevalence of tuberculosis and bacteraemia in Bangladeshi children with severe malnutrition and pneumonia including an evaluation of Xpert MTB/RIF assay. 2014;9(4):e93776. pmid:24695758
25. Roth A, Garly M, Jensen H, Nielsen J, Aaby PJErov. Bacillus Calmette-Guerin vaccination and infant mortality. 2006;5(2):277–93. pmid:16608427
26. Chowdhury F, Shahid ASMSB, Ghosh PK, Rahman M, Hassan MZ, Akhtar Z, et al. Viral etiology of pneumonia among severely malnourished under-five children in an urban hospital, Bangladesh. PloS one. 2020;15(2):e0228329. pmid:32017782
27. Alam NH, Ashraf H. Treatment of infectious diarrhea in children. Pediatric Drugs. 2003;5(3):151–65. pmid:12608880
28. Ashraf H, Jobayer M, Alam N. Treatment of childhood pneumonia in developing countries. Health management Sciyo. 2010:59–88.
29. Shahid ASMSB, Alam T, Shahrin L, Shahunja K, Sarmin M, Afroze F, et al. Early management of hypokalaemia in severely malnourished children under five could help to reduce deaths in developing countries. Acta Paediatrica. 2021;110(5):1658–64. pmid:33089512
30. Levy MM, Dellinger RP, Townsend SR, Linde-Zwirble WT, Marshall JC, Bion J, et al. The Surviving Sepsis Campaign: results of an international guideline-based performance improvement program targeting severe sepsis. Intensive care medicine. 2010;36(2):222–31. pmid:20069275
31. Kirk R, Dipchand AI, Rosenthal DN, Addonizio L, Burch M, Chrisant M, et al. Erratum: The international society of heart and lung transplan-tation Guidelines for the management of pediatric heart failure: Executive summary (Journal of Heart and Lung Transplantation (2014) 33: 9 (888–909)). Journal of Heart and Lung Transplantation. 2014;33(10).
32. Kortz TB, Axelrod DM, Chisti MJ, Kache S. Clinical outcomes and mortality before and after implementation of a pediatric sepsis protocol in a limited resource setting: A retrospective cohort study in Bangladesh. Plos one. 2017;12(7):e0181160. pmid:28753618
33. Chisti MJ, Ahmed T, Bardhan PK, Salam MA. Evaluation of simple laboratory investigations to predict fatal outcome in infants with severe malnutrition presenting in an urban diarrhoea treatment centre in Bangladesh. Tropical Medicine & International Health. 2010;15(11):1322–5.
34. Chisti MJ, Ahmed T, Ahmed AS, Sarker SA, Faruque ASG, Islam MM, et al. Hypernatremia in children with diarrhea: presenting features, management, outcome, and risk factors for death. Clinical pediatrics. 2016;55(7):654–63. pmid:26810623
35. Chisti MJ, Salam MA, Bardhan PK, Faruque AS, Shahid AS, Shahunja K, et al. Severe sepsis in severely malnourished young Bangladeshi children with pneumonia: a retrospective case control study. PLoS One. 2015;10(10):e0139966. pmid:26440279
36. Shann F, Nohynek H, Scott JA, Hesseling A, Flanagan KL. Randomized trials to study the nonspecific effects of vaccines in children in low-income countries. The Pediatric infectious disease journal. 2010;29(5):457–61. pmid:20431383
37. Shann F. Nonspecific effects of vaccines and the reduction of mortality in children. Clinical therapeutics. 2013;35(2):109–14. pmid:23375475
38. Rebhan B, Kohlhuber M, Schwegler U, Fromme H, Abou‐Dakn M, Koletzko BV. Breastfeeding duration and exclusivity associated with infants’ health and growth: data from a prospective cohort study in Bavaria, Germany. Acta Paediatrica. 2009;98(6):974–80. pmid:19484835
39. Duijts L, Jaddoe VW, Hofman A, Moll HA. Prolonged and exclusive breastfeeding reduces the risk of infectious diseases in infancy. Pediatrics. 2010;126(1):e18–e25. pmid:20566605
40. Oddy W, Sly P, De Klerk N, Landau L, Kendall G, Holt P, et al. Breast feeding and respiratory morbidity in infancy: a birth cohort study. Archives of disease in childhood. 2003;88(3):224–8. pmid:12598384
41. Etiler N, Velipasaoglu S, Aktekin M. Incidence of acute respiratory infections and the relationship with some factors in infancy in Antalya, Turkey. Pediatrics international. 2002;44(1):64–9. pmid:11982874
42. Cushing AH, Samet JM, Lambert WE, Skipper BJ, Hunt WC, Young SA, et al. Breastfeeding reduces risk of respiratory illness in infants. American journal of epidemiology. 1998;147(9):863–70. pmid:9583717
43. Oddy WH. Breastfeeding protects against illness and infection in infants and children: a review of the evidence. Breastfeeding Review. 2001;9(2).
44. Ashine YE, Ayele BA, Aynalem YA, Yitbarek GY. Time to Death and its Predictor Among Children Under Five Years of Age with Severe Acute Malnutrition Admitted to Inpatient Stabilization Centers in North Shoa Zone, Amhara Region, Ethiopia. Nutrition and Dietary Supplements. 2020;12:167–77.
45. Simon AK, Hollander GA, McMichael A. Evolution of the immune system in humans from infancy to old age. Proceedings of the Royal Society B: Biological Sciences. 2015;282(1821):20143085. pmid:26702035
46. Chisti M, Salam M, Ahmed T, Shahid A, Shahunja K, Faruque A, et al. Lack of BCG vaccination and other risk factors for bacteraemia in severely malnourished children with pneumonia. Epidemiology & Infection. 2015;143(4):799–803. pmid:24892696
47. Roy P, Vekemans J, Clark A, Sanderson C, Harris RC, White RG. Potential effect of age of BCG vaccination on global paediatric tuberculosis mortality: a modelling study. The Lancet Global Health. 2019;7(12):e1655–e63. pmid:31708146
48. Hirve S, Bavdekar A, Juvekar S, Benn CS, Nielsen J, Aaby P. Non-specific and sex-differential effects of vaccinations on child survival in rural western India. Vaccine. 2012;30(50):7300–8. pmid:23022401
49. Ritz N, Mui M, Balloch A, Curtis N. Non-specific effect of Bacille Calmette-Guerin vaccine on the immune response to routine immunisations. Vaccine. 2013;31(30):3098–103. pmid:23583897
50. Nankabirwa V, Tumwine JK, Mugaba PM, Tylleskär T, Sommerfelt H. Child survival and BCG vaccination: a community based prospective cohort study in Uganda. BMC Public Health. 2015;15(1):1–10. pmid:25886062
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
© 2022 Ackhter et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Abstract
Background
Bacillus Calmette-Guérin (BCG) vaccination has recently been found to have beneficial effects among children infected other than Mycobacterium tuberculosis. Due to the paucity of data on the outcomes of children who had successful BCG vaccination following Expanded Programme on Immunization (EPI) schedule, we aimed to investigate the characteristics of such children and their outcomes who were hospitalized for severe malnutrition.
Methods
A prospective observational study was conducted to determine the viral etiology of pneumonia in severely malnourished children those were admitted to the Dhaka Hospital of International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b) between April 2015 and December 2017, constituted the study population. Using a case-control design for the analysis, children having BCG vaccination prior hospital admission were treated as cases (n = 611) and those without vaccination, constituted as controls (n = 83). Bi-variate analysis was conducted using socio-demographic, clinical, laboratory, and treatment characteristics on admission and outcomes during hospitalization. Finally, log-linear binomial regression analysis was done to identify independent impact of BCG vaccination.
Results
The cases more often presented with older age, have had lower proportion of maternal illiteracy, higher rate of breastfeeding, severe wasting and lower rate of hypoglycemia, compared to the controls. The cases were also found to have lower risk of severe sepsis and deaths, compared to the controls (for all, p<0.05). However, in log-linear binomial regression analysis, after adjusting for potential confounders, BCG vaccination following EPI schedule (RR:0.54; 95%CI = 0.33–0.89; p = 0.015) and breastfeeding (RR:0.53; 95%CI = 0.35–0.81; p = 0.003) were found to be protective for the development of severe sepsis.
Conclusion
BCG vaccination and breastfeeding were found to be protective for the development of severe sepsis in hospitalized severely malnourished under-five children which underscores the importance of continuation of BCG vaccination at birth and breastfeeding up to two years of age.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer